{
  "id": 17812569,
  "title": "FDA puts Bright Minds drug on partial hold, stock tanks",
  "url": "https://urgent.news/2026/11/02/fda-puts-bright-minds-drug-on-partial-hold-stock-tanks",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-02T15:11:58.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/fda-puts-bright-minds-drug-on-partial-hold-stock-tanks/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The FDA placed an experimental seizure drug from Bright Minds Biosciences on a partial clinical hold, the company announced Monday. Regulators issued the hold for BMB-101 after identifying toxicity issues in preclinical mouse models, Bright ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Why is Bright Minds Biosciences stock collapsing today?",
        "url": "https://urgent.news/2026/11/02/why-is-bright-minds-biosciences-stock-collapsing-today",
        "published": "2026-11-02T14:59:10.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}